EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudieOpen Access · CC BY 4.0

Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer’s disease spectrum

Alessandro Padovani, Salvatore Caratozzolo, Alice Galli, Luca Crosani, Silvio Zampini, Maura Cosseddu, Rosanna Turrone, Andrea Zancanaro, Bianca Gumina, Barbara Vicini-Chilovi, Alberto Benussi, Andrey Vyshedskiy und 1 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-024-07775-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Neurological Sciences, 2025. Verfasst von Alessandro Padovani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Mental Status and Dementia Tests, Neuropsychological Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Boston Cognitive Assessment (BOCA) is a self-administered online test developed for cognitive screening and longitudinal monitoring of brain health in an aging population. The study aimed to validate BOCA in an Italian population and to investigate the convergent validity with the Montreal Cognitive Assessment (MOCA) in healthy ageing population and patients within the Alzheimer Disease spectrum.

Methods

BOCA was administered to 150 participants, including cognitively healthy controls (HC, n = 50), patients with mild cognitive impairment (MCI, n = 50), and dementia (DEM, n = 50). The BOCA reliability was assessed using (i) Spearman’s correlation analysis between subscales; (ii) Cronbach’s alpha calculation, and (iii) Principal Component Analysis. Repeated-measures ANOVA was employed to assess the impact of the sequence of test administrations between the groups. BOCA performance between HS, MCI and DEM and within different severity subgroups were compared using Kruskall Wallis test. Furthermore, a comparison was conducted between MCI patients who tested positive for amyloid and those who tested negative, utilizing Mann Whitney’s U-test.

Results

Test scores were significantly different between patients and controls ( p < 0.001) suggesting good discriminative ability. The Cronbach’s alpha was 0.82 indicating a good internal consistency of the BOCA subscales and strong-to-moderate Spearman’s correlation coefficients between them. BOCA total and subscores differ across different MoCA severity subgroups and demonstrated strong correlation with MoCA scores (rho = 0.790, p < 0.001).

Conclusions

The Italian version of the BOCA test exhibited validity, feasibility, and accurate discrimination closely performing as MoCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionMental Status and Dementia TestsNeuropsychological TestsHumansMaleFemaleAgedItalyReproducibility of ResultsAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloidBOCADigital cognitive testingMoCa

Autor:innen und Institutionen

  • Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Department of continuity of care and frailty, Neurology Unit, ASST Spedali Civili Hospital, Brescia, Italy.
  • Neurobiorepository and Laboratory of advanced biological markers, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy.
  • Laboratory of digital Neurology and biosensors, University of Brescia, Brescia, Italy.
  • Brain Health Center, University of Brescia, Brescia, Italy.
  • Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. salvatore.caratozzolo@hotmail.com.

Zitieren

APA

Padovani, A., Caratozzolo, S., Galli, A., Crosani, L., Zampini, S., Cosseddu, M., Turrone, R., Zancanaro, A., Gumina, B., Vicini-Chilovi, B., Benussi, A., Vyshedskiy, A., & Pilotto, A. (2025). Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer’s disease spectrum. Neurological Sciences. https://doi.org/10.1007/s10072-024-07775-3

Vancouver

Padovani A, Caratozzolo S, Galli A, Crosani L, Zampini S, Cosseddu M, et al. Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer’s disease spectrum. Neurological Sciences. 2025. doi:10.1007/s10072-024-07775-3

BibTeX
@article{Padovani2025,
  author = {Padovani, Alessandro and Caratozzolo, Salvatore and Galli, Alice and Crosani, Luca and Zampini, Silvio and Cosseddu, Maura and Turrone, Rosanna and Zancanaro, Andrea and Gumina, Bianca and Vicini-Chilovi, Barbara and Benussi, Alberto and Vyshedskiy, Andrey and Pilotto, Andrea},
  title = {Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer’s disease spectrum},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-024-07775-3}
}
Kostenlos starten →